The Cartagena Cohort Study
Launched by UNIVERSIDAD DE CARTAGENA · Apr 14, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults
- • Native from Colombian Caribbean Coast
- Exclusion Criteria:
- • Pregnant women
- • Walking physical disability
- • Cognitive disability
- • Patients under treatment for any type of cancer
- • Clinical record of primary chronic endocrine disease
- • Clinical record of major respiratory tract surgery
About Universidad De Cartagena
The Universidad de Cartagena is a prestigious academic institution located in Colombia, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving healthcare outcomes. With a focus on ethical standards and scientific rigor, the Universidad de Cartagena collaborates with multidisciplinary teams to conduct clinical trials that address critical health challenges, ultimately contributing to evidence-based practices and enhancing the quality of care in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cartagena De Indias, Bolivar, Colombia
Patients applied
Trial Officials
GUSTAVO J MORA-GARCIA, PhD
Principal Investigator
Universidad de Cartagena
VANESSA GARCIA-LARSEN, PhD
Study Director
BLOOMBERG SCHOOL OF PUBLIC HEALTH JOHNS HOPKINS UNIVERSITY
MARIA S RUIZ-DIAZ, PhD
Study Chair
NATIONAL CENTER FOR RESEARCH IN CHRONIC DISEASES
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials